Cardiac 123I-MIBG scintigraphy in patients with essential tremor

Movement Disorders

Volumn 21, Issue 8, 2006, Pages 1235-1238

  Lee, Phil Hyu ^a   Kim, Ji Woo ^a   Bang, Oh Young ^a   Joo, In Soo ^a   Yoon, Seok Nam ^a   Huh, Kyoon ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

Cardiac MIBG; Essential tremor; Parkinson's disease

Indexed keywords

(3 IODOBENZYL)GUANIDINE; IODINE 123; DIAGNOSTIC AGENT; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT;

ADRENERGIC SYSTEM; ADULT; AGED; ARTICLE; AUTONOMIC DYSFUNCTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE DURATION; ESSENTIAL TREMOR; FEMALE; HEART SCINTISCANNING; HUMAN; MALE; MEDIASTINUM; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; STATISTICAL ANALYSIS; HEART; HEART DISEASE; MIDDLE AGED; PATHOPHYSIOLOGY; SCINTISCANNING;

3-IODOBENZYLGUANIDINE; AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; ESSENTIAL TREMOR; FEMALE; HEART; HEART DISEASES; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PARKINSON DISEASE; RADIOPHARMACEUTICALS;

EID: 33748374485     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.20908     Document Type: Article

References (19)

1. Louis ED. Essential tremor. Lancet Neurol 2005;4: 100-110.
2. Deuschl G, Bain P, Brin M. Consensus statement of the Movement Disorder Society on Tremor: Ad Hoc Scientific Committee. Mov Disord 1998;3(Suppl.):2-23.
3. Montgomery EB Jr, Baker KB, Lyons K, et al. Motor initiation and execution in essential tremor and Parkinson's disease. Mov Disord 2000;15:511-515.
4. Richards M, Stern Y, Mayeux R. Subtle extrapyramidal signs can predict the development of dementia in elderly individuals. Neurology 1993;43:2184-2188.
5. Cohen O, Pullman S, Jurewicz E, et al. Rest tremor in patients with essential tremor: prevalence, clinical correlates, and electrophysiologic characteristics. Arch Neurol 2003;60:405-410.
6. Solanki KK, Bomanji J, Moyes J, et al. A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG). Nucl Med Commun 1992;13:513-521.
7. Goldstein DS, Dysautonomia in Parkinson's disease: neurocardiological abnormalities. Lancet Neurol 2003;2:669-676.
8. Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinsonism a clinico-pathological study of 100 cases. I Neurol Neurosurg Psychiatry 1992;55:181-184.
9. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442.
10. Jankovic J, McDermott M, Carter J, et al., for the Parkinson Study Group. Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. Neurology 1990;40,1529-1534.
11. Fahn S, Elton RL, UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In., Fahn S, Marsden CD, Calne D, et al., editors. Recent development in Parkinson's disease, vol 2. Florham Park, NJ: Macmillan Healthcare Information; 1987. p 153-163.
12. Findley LJ. Classification of tremors. J Clin Neurophysiol 1996; 13:122-132.
13. Lombardi WJ, Woolston DJ, Roberts WJ, et al. Cognitive deficits in patients with essential tremor. Neurology 2001;57:785-790.
14. Louis ED, Bromley SM, Jurewicz EC, et al. Olfactory dysfunction in essential tremor: a deficit unrelated to disease duration or severity. Neurology 2002;59:1631-1633.
15. Brooks DJ, Playford ED, Ibanez V, et al. Isolated tremor and disruption of the nigrostriatal dopaminergic system: an 18F-dopa PET study. Neurology 1992;42:1554-1560.
16. 123I-IPT brain SPECT study in essential tremor and Parkinson's disease. Neurology 1999;52:1422-1426.
17. 123I]beta-CIT and SPECT in essential tremor and Parkinson's disease. J Neural Transm 1998;105:1213-1228.
18. 123I]-FP-CIT study group. Mov Disord 2000;15:503-510.
19. Rajput AH, Rozdilsky B, Ang L, et al. Significance of parkinsonian manifestations in essential tremor. Can J Neurol Sci 1993;20:114-117.